1. Albert M, DeCarli CS, DeKosky ST, de Leon MJ, Foster NL, Fox NC, Frank R, Frackowiak RS, Jack CR, Jagust WJ, Knopman DS, Morris JC, Petersen RC, Reiman E, Scheltens P, Small G, Soininen H, Thal L, Wahlund L-O, Thies W, Weiner M, Khachaturian Z (2005) The use of MRI and PET for clinical diagnosis of dementia and investigation of cognitive impairment: a consensus report. In: Neuroimaging Work Group of the Alzheimer’s Association Consensus Report, pp 1–15
2. Alzheimer A (1911) Über eigenartige krankheitsfälle des späteren alters. Zbl Ges Neurol Psych 4:356–385
3. Anazodo UC, Finger E, Yin Ming Kwan B, Pavlosky W, Warrington JC, Günther M, Prato FS, Thiessen JD, St. Lawrencea KS (2017) Using simultaneous PET/MRI to compare the accuracy of diagnosing frontotemporal dementia by arterial spin labelling MRI and FDG-PET. Neuroimage Clin 17:405–414
4. Archer HA, Smailagic N, John C, Holmes RB, Takwoingi Y, Coulthard EJ, Cullum S (2015) Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia. Cochrane Database Syst Rev 6:CD010896
5. Asghar M, Hinz R, Herholz K, Carter SF (2019) Dual-phase [18F]florbetapir in frontotemporal dementia. Eur J Nucl Med Mol Imaging 46(2):304–311